Literature DB >> 7523767

The role of endothelium in cardiovascular homeostasis and diseases.

G M Rubanyi1.   

Abstract

Key discoveries in the past decade have revealed that the vascular endothelium is an important regulatory organ that is involved in maintaining cardiovascular homeostasis in health and contributes significantly to the pathomechanism of several cardiovascular diseases. Occupying a strategically important location between circulating blood and tissues and having the ability to respond to changes in its physical, chemical, and humoral environment by the production of a host of biologically active substances, the normal endothelium modulates the tone of underlying vascular smooth muscle, maintains a nonadhesive luminal surface, and mediates hemostasis, cellular proliferation, and inflammatory and immune mechanisms in the vascular wall. Modulation of smooth-muscle tone is mediated by the synthesis release of endothelium-derived relaxing [PGI2, EDRF(NO), and EDHF] and contracting factors (arachidonic acid metabolites, endothelin-1, and angiotensin II). Anticoagulant, fibrinolytic, and antithrombotic properties contribute to the maintenance of the fluidity of blood. Injury or activation (by cytokines) of endothelial cells disrupts these normal regulatory mechanisms and results in morphologic and functional alterations (phenotypic changes) commonly defined as endothelial dysfunction. Clinically, the "syndrome" of endothelial cell dysfunction can be described as generalized or localized vasospasm, thrombosis, atherosclerosis, and restenosis. Although its importance is clearly established, no drugs used today were originally targeted for the treatment of endothelial dysfunction. Recent studies, however, showed that some existing therapies (e.g., angiotensin-converting enzyme inhibitors) may protect the endothelium. Novel diagnostic techniques and innovative therapeutic strategies, based on the already known molecular mechanisms of endothelial dysfunction, are briefly outlined. Further knowledge of the pathobiology of the impaired endothelium will contribute to unraveling some of the remaining mysteries of many cardiovascular diseases and will enable us to design novel therapies to prevent and treat them.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7523767     DOI: 10.1097/00005344-199322004-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  89 in total

1.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Authors:  T Lauer; M Preik; T Rassaf; B E Strauer; A Deussen; M Feelisch; M Kelm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension.

Authors:  T Santoso
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 3.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Ageing, exercise training, and resistance vessels: more than just no NO?

Authors:  Frank A Dinenno
Journal:  J Physiol       Date:  2004-03-19       Impact factor: 5.182

5.  Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells.

Authors:  Jamila H Siamwala; S Himabindu Reddy; Syamantak Majumder; Gopi Krishna Kolluru; Ajit Muley; Swaraj Sinha; Suvro Chatterjee
Journal:  Protoplasma       Date:  2010-02-20       Impact factor: 3.356

Review 6.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

7.  Endothelium-dependent and-independent relaxation induced by resveratrol in rat superior mesenteric arteries.

Authors:  Yulong Chen; Cangbao Xu; Yahui Wei; Yaping Zhang; Ailan Cao
Journal:  Exp Ther Med       Date:  2016-08-22       Impact factor: 2.447

8.  Mechanisms of simvastatin-induced vasodilatation of rat superior mesenteric arteries.

Authors:  Yulong Chen; Hongmei Zhang; Huanhuan Liu; Ailan Cao
Journal:  Biomed Rep       Date:  2016-09-12

9.  The endothelium in health and disease: A discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.

Authors:  Chris R Triggle; Hong Ding; Todd J Anderson; Malarvannan Pannirselvam
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts.

Authors:  Helen M Nugent; Robert Tjin Tham Sjin; Desmond White; Luther G Milton; Roberto J Manson; Jeffrey H Lawson; Elazer R Edelman
Journal:  J Vasc Surg       Date:  2007-09       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.